导师风采
王靖
个人信息
Personal Information
- 性别：女
- 导师类型：博士生导师
- 职称：主任医师
- 该职称任职时间：17
联系方式
Contact Information
- 所属院系：肿瘤医院
- 所属专业：
- 邮箱 : wwwjjj1234@vip.sina.com
- 工作电话 : 010-87787678
个人简介
Personal Profile
中国医学科学院肿瘤医院乳腺外科科室主任，擅长乳腺肿瘤的外科治疗，在国内较早开展乳腺癌术后乳房即刻再造、保乳及肿瘤整形等手术，年门诊量4500余人次，年手术量1100余台。开展乳腺疾病相关临床和基础研究，主持/作为项目骨干参与国家/省部级课题10余项，主持全国多中心前瞻性临床试验3项，在国内外期刊发表学术论文70余篇。兼任中国医疗保健国际交流促进会乳腺疾病防治分会常务理事、主任委员，中国整形美容协会肿瘤整复分会副主任委员、秘书长，北京肿瘤学会乳腺外科专业委员会副主任委员、秘书长，中国抗癌协会乳腺癌专业委员会常委，中国临床肿瘤学会乳腺癌专家委员会常委，中国医疗保健国际交流促进会常务理事，中国整形美容协会乳房整形分会常委，北京医学会乳腺疾病委员会常委，中国医疗保健国际交流促进会肿瘤整形外科与功能性外科分会常委等职务。
团队简介
Team Profile
待补充更新
- 研究方向Research Directions
乳腺癌,乳腺肿瘤
- 在校研究生Current Graduate Students
硕士研究生 0 名，博士研究生 6 名
- 科研项目Research Projects
| # | 项目名称 | 起止日期 | 金额 | 项目类型 | 本人角色 |
|---|---|---|---|---|---|
| 1 | 天然化合物治疗三阴性乳腺癌新策略：装载新藤黄酸的pH级联响应性载氧型多功能纳米递药系统的应用及机制研究 | 2022-01-01 —— 2025-12-31 | 80.7 | 主持在研的国家或省部级科研项目 | 主持者 |
| 2 | DDX11与FOXR2 相互作用在HER2 阳性乳腺癌曲妥珠单抗耐药的功能研究 | 2019-01-01 —— 2022-12-31 | 57.0 | 主持在研的国家或省部级科研项目 | 主持者 |
| 3 | 长链非编码RNA LINC00092影响HER2阳性乳腺癌曲妥珠单抗耐药机制研究 | 2019-01-01 —— 2022-12-31 | 60.0 | 主持在研的国家或省部级科研项目 | 主持者 |
| 4 | 乳腺癌赫赛汀耐药新机制：HOTTIP通过甲基化调控作用激活HER2和EMT通路 | 2020-04-14 —— 2021-12-01 | 10.0 | 参与在研的国家或省部级科研项目 | 参与者 |
- 发表论文Papers
| # | 论文题目 | 期刊名称 | 发表年份 | 论文署名 |
|---|---|---|---|---|
| 1 | Conditional Survival of female patients with operable invasive Breast Cancer in US: A population-based study | Journal of Cancer | 2022-06-21 | 王靖 |
| 2 | Variation in Breast Cancer Subtype Incidence and Distribution by Race/Ethnicity in the United States from 2010 to 2015 | JAMA Network Open | 2022-06-21 | 王靖 |
| 3 | Recent Progress for the Techniques of MRI-Guided Breast Interventions and their applications on SurgicaL Strategy | Journal of Cancer | 2022-06-21 | 王靖 |
| 4 | 放疗及其时机对组织扩张器-假体植入乳房重建的影响及研究进展 | 中华放射肿瘤学杂志 | 2022-06-21 | 王靖 |
| 5 | Oncotype DX Breast Recurrence Score Distribution and Chemotherapy Benefit Among Women of Different Age Groups with HR-Positive, HER2-Negative, Node-Negative Breast Cancer in the SEER Database | Frontiers in Oncology | 2022-06-21 | 王靖 |
| 6 | Nutritional Risk Index Predicts Survival in Patients With Breast Cancer Treated With Neoadjuvant Chemotherapy | Frontiers in Nutrition | 2022-06-21 | 王靖 |
| 7 | Melatonin: A Potential Therapeutic Option for Breast Cancer | TRENDS IN ENDOCRINOLOGY AND METABOLISM | 2022-06-21 | 王靖 |
| 8 | LINC01355 suppresses breast cancer growth through FOXO3-mediated transcriptional repression of CCND1 | Cell Death & Disease | 2022-06-21 | 王靖 |
| 9 | Association between aesthetic satisfaction and chronic postsurgical pain in breast cancer patients treated with one stage prosthesis implantation | Scientific Reports | 2022-06-21 | 王靖 |
| 10 | A Novel Prognostic Signature of mRNA-lncRNA in Breast Cancer | DNA AND CELL BIOLOGY | 2022-06-21 | 王靖 |
| 11 | Molecular and Clinical Characterization of PD-1 in Breast Cancer Using Large-Scale Transcriptome Data | Frontiers in Immunology | 2022-06-21 | 王靖 |
| 12 | Comprehensive Analysis of the Expression and Prognosis for TDO2 in Breast Cancer | Molecular Therapy-Oncolytics | 2022-06-21 | 王靖 |
| 13 | 5G网络技术在医疗领域的应用前景 | 医学信息学杂志 | 2022-06-21 | 王靖 |
| 14 | Nanomedicines inhibiting tumor metastasis and recurrence and their clinical applications | Nano Today | 2022-06-21 | 王靖 |
| 15 | ESTIMATE algorithm is not appropriate for inferring tumor purity and stromal and immune cell admixture in hematopoietic or stromal tumors | CANCER IMMUNOLOGY IMMUNOTHERAPY | 2022-06-21 | 王靖 |
| 16 | Association of circulating Progesterone Receptor Membrane Component-1(PGRMC1) with PGRMC1 expression in breast tumour tissue and witclinical breast tumour characteristicsh | MATURITAS | 2022-06-21 | 王靖 |
| 17 | Pretreatment Systemic Inflammation Response Index in Patients with Breast Cancer Treated with Neoadjuvant Chemotherapy as a Useful Prognostic Indicator | Cancer Management and Research | 2022-06-21 | 王靖 |
| 18 | Omitting ALND Is Not Safe for a Cohort of Early-Stage Breast Cancer Patients with 1-2 SLNs Macro-Metastases and Breast-Conserving Therapy: A Single-Center Retrospective Study | IRANIAN JOURNAL PUBLIC HEALTH | 2022-06-21 | 王靖 |
| 19 | Prognostic Nutritional Index (PNI) in Patients With Breast Cancer Treated With Neoadjuvant Chemotherapy as a Useful Prognostic Indicator | Frontiers in Cell and Developmental Biology | 2022-06-21 | 王靖 |
| 20 | 全身炎症反应指数（SIRI）在乳腺患者中的临床意义和预后价值 | 现代肿瘤医学 | 2022-06-21 | 王靖 |
| 21 | Research Progress Concerning Dual Blockade of Lymphocyte-Activation Gene 3 and Programmed Death- 1/Programmed Death-1 Ligand-1 Blockade in Cancer Immunotherapy: Preclinical and Clinical Evidence of This Potentially More Effective Immunotherapy Strategy | Frontiers in Immunology | 2022-06-21 | 王靖 |
| 22 | The Prognostic Significance of Anisomycin-Activated Phospho-c-Jun NH2-Terminal Kinase (p-JNK) in Predicting Breast Cancer Patients' Survival Time | Frontiers in Cell and Developmental Biology | 2022-06-21 | 王靖 |
| 23 | Mechanism of trastuzumab resistance caused by HER-2 mutation in breast carcinomas | Cancer Management and Research | 2022-06-21 | 王靖 |
| 24 | Factors associated with chemotherapy beneft in breast cancer patients with midrange oncotype DX breast recurrence scores | CANCER LETTERS | 2022-06-21 | 王靖 |
| 25 | 外周血中常见血液学参数对乳腺癌预后评估价值的研究进展 | 现代生物医学进展 | 2022-06-21 | 王靖 |
| 26 | Patient-Reported Outcomes and Complications following Breast Reconstruction: A Comparison between Biological Matrix-Assisted Direct to-Implant and Latissimus Dorsi Flap | Frontiers in Oncology | 2022-06-21 | 王靖 |
| 27 | Research Progresses in Immunological Checkpoint Inhibitors for Breast Cancer Immunotherapy | Frontiers in Oncology | 2022-06-21 | 王靖 |
| 28 | The Systemic Immune-inflammation Index is an Independent Predictor of Survival in Breast Cancer Patients | Cancer Management and Research | 2022-06-21 | 王靖 |
| 29 | Letter regarding Sopik V et al. entitled "Impact of microinvasion on breast cancer mortality in women with ductal carcinoma in situ | Breast Cancer Research and Treatment | 2022-06-21 | 王靖 |
| 30 | Prognostic Alternative mRNA Splicing Signature and a Novel Biomarker in Triple-Negative Breast Cancer | DNA AND CELL BIOLOGY | 2022-06-21 | 王靖 |
| 31 | Identification of the Significant Genes Regulated by Estrogen Receptor in Estrogen Receptor-Positive Breast Cancer and Their Expression Pattern Changes When Tamoxifen or Fulvestrant Resistance Occurs | Frontiers in Genetics | 2022-06-21 | 王靖 |
| 32 | Comparisons of Therapeutic and Aesthetic Effects of One-Stage Implant-Based Breast Reconstruction with and without Biological Matrix | Cancer Management and Research | 2022-06-21 | 王靖 |
| 33 | Comparisons of Therapeutic and Aesthetic Effects of One-Stage Implant-Based Breast Reconstruction with and without Biological Matrix | Cancer Management and Research | 2022-06-21 | 王靖 |
| 34 | 乳腺癌术后即刻背阔肌肌皮瓣/肌瓣乳房重建术研究进展 | 中华实用诊断与治疗杂志 | 2022-06-21 | 王靖 |
| 35 | Pre-treatment systemic immune-inflammation index is a useful prognostic indicator in patients with breast cancer undergoing neoadjuvant chemotherapy | JOURNAL OF CELLULAR AND MOLECULAR MEDICINE | 2022-06-21 | 王靖 |
| 36 | 乳腺癌与甲状腺癌双原发癌临床特点及预后分析 | 中华肿瘤杂志 | 2022-06-21 | 王靖 |
- 科研获奖Research Awards
无
- 研究成果Research Findings
无